VRG Therapeutics (VRG Tx) is an innovative biopharmaceutical R&D company headquartered in Budapest, Hungary. VRG Tx is committed to leveraging its proprietary miniprotein ISEP technology to tackle diseases through mechanism of actions that conventional biopharma cannot reach. We optimize peptides/proteins of natural origin using directed evolution to create cutting-edge CGT products or peptide-based pharmaceuticals with unprecedented selectivity and affinity.